Cardiovascular Journal of Africa: Vol 31 No 2 (March/April 2020)

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 2, March/April 2020

AFRICA

101

Global Outcomes.

Kidney Int

2007;

: 247–259.

Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney

disease: a global challenge.

Kidney Int

2005;

: S11–S17.

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney

disease and the risks of death, cardiovascular events, and hospitaliza-

tion.

N Engl J Med

2004;

351

: 1296–1305.

Chronic Kidney Disease Prognosis Consortium, Matsushita K, van

der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE,

et al

Association of estimated glomerular filtration rate and albuminuria

with all-cause and cardiovascular mortality in general population

cohorts: a collaborative meta-analysis.

Lancet

2010;

375

: 2073–2081.

Mahmoodi BK, Matsushita K, Woodward M, Blankestjin PJ, Cirillo

M, Ohkubo T,

et al

. Chronic Kidney Disease Prognosis Consortium.

Associations of kidney disease measures with mortality and end-stage

renal disease in individuals with and without hypertension: a meta-

analysis.

Lancet

2012;

380

: 1649–1661.

Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E,

et al

CKD Prognosis Consortium. Estimated glomerular filtration rate and

albuminuria for prediction of cardiovascular outcomes: a collaborative

meta-analysis of individual participant data.

Lancet Diabetes Endocrinol

2015;

: 514–525.

Waheed S, Matsushita K, Sang Y, Hoogeveen R, Ballantyne C, Coresh

et al

. Combined association of albuminuria and cystatin C-based

estimated GFR with mortality, coronary heart disease, and heart failure

outcomes: The Atherosclerosis Risk in Communities (ARIC) Study.

J Kidney Dis

2012;

: 207–216.

Hui X, Matsushita K, Sang Y, Ballew SH, Fu¨lo¨p T, Coresh J. CKD

and cardiovascular disease in the Atherosclerosis Risk in Communities

(ARIC) study: interactions with age, sex, and race.

Am J Kidney Dis

2013;

: 691–702.

Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass

index and the risk of development of end-stage renal disease in a

screened cohort.

Kidney Int

2004;

: 1870–1876.

10. Kramer HJ, Saranathan A, Luke A, Durazo-Arvizu RA, Guichan C,

Hou S,

et al

. Increasing body mass index and obesity in the incident

ESRD population.

J Am Soc Nephrol

2006;

: 1453–1459.

11. Ejerblad E, Fored MC, Lindblad P, Fryzek J, McLaughlin JK, Nyrén

O. Obesity and risk for chronic renal failure.

J Am Soc Nephrol

2006;

: 1695–1702.

12. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M,

Haffner SM. Microalbuminuria is associated with insulin resistance

in nondiabetic subjects: The Insulin Resistance Atherosclerosis Study.

Diabetes

1998;

: 793–800.

13. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK,

. Insulin resistance and risk of chronic kidney disease in non-diabetic

US adults.

J Am Soc Nephrol.

2003;

: 469–477.

14. Whaley-Connell A, Pavey BS, McCullough PA, Saab G, Li S, McFarlane

SI,

et al

. KEEP Investigators. Dysglycemia predicts cardiovascular

and kidney disease in the Kidney Early Evaluation Program.

J Clin

Hypertens (Greenwich)

2010;

: 51–58.

15. ox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors

of new-onset kidney disease in a community-based population.

J Am

Med Assoc

2004;

: 844–850.

16. Fried L, Solomon C, Shlipak M, Seliger S, Stehman-Breen C, Bleyer

AJ,

et al

. Inflammatory and prothrombotic markers and the progres-

sion of renal disease in elderly individuals.

J Am Soc Nephrol

2004;

3184–3191.

17. Cabré A, Lázaro I, Girona J, Manzanares J, Marimón F, Plana N,

et al

Retinol-binding protein 4 as a plasma biomarker of renal dysfunction

and cardiovascular disease in type 2 diabetes.

J Intern Med

2007;

262

496–503.

18. Axelsson J, Stenvinkel P. Role of fat mass and adipokines in chronic

kidney disease.

Curr Opin Nephrol Hypertens

2008;

: 25–31.

19. Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor

BC. Inflammation, hemostasis, and the risk of kidney function decline

in the Atherosclerosis Risk in Communities (ARIC) Study.

Am J Kidney

Dis

2009;

: 596–605.

20. Keller C, Katz R, Sarnak MJ, Fried LF, Kestenbaum B, Cushman M,

al.

CHS study. Inflammatory biomarkers and decline in kidney function

in the elderly: the Cardiovascular Health Study.

Nephrol Dial Transpl

2010;

: 119–124.

21. Kawamura R, Doi Y, Osawa H, Ninomiya T, Hata J, Yonemoto K,

al.

Circulating resistin is increased with decreasing renal function in a

general Japanese population: the Hisayama Study.

Nephrol Dial Transpl

2010;

: 3236–3240.

22. Shankar A, Sun L, Klein BE, Lee KE, Muntner P, Nieto FJ,

et al.

Markers of inflammation predict the long-term risk of developing

chronic kidney disease: a population-based cohort study.

Kidney Int

2011;

: 1231–1238.

23. Upadhyay A, Larson MG, Guo CY, Vasan RS, Lipinska I, O’Donnell

CJ,

et al

. Inflammation, kidney function and albuminuria in the

Framingham Offspring cohort.

Nephrol Dial Transpl

2011;

: 920–926.

24. Hiramoto JS, Katz R, Peralta CA, Ix JH, Fried L, Cushman M,

et al

Inflammation and coagulation markers and kidney function decline: the

MultiEthnic Study of Atherosclerosis (MESA).

Am J Kidney Dis

2012;

: 225–232.

25. Menzaghi C, Salvemini L, Fini G, Thompson R, Mangiacotti D, Di

Paola R,

et al.

Serum resistin and kidney function: a family-based study

in non-diabetic, untreated individuals.

PLoS One

2012;

: e38414

26. Mills KT, Hamm LL, Alper AB, Miller C, Hudaihed A, Balamuthusamy

et al

. Circulating adipocytokines and chronic kidney disease.

PLoS

One

2013;

: e76902.

27. An JN, Yoo KD, Hwang JH, Kim HL, Kim SH, Yang SH,

et al

Circulating tumour necrosis factor receptors 1 and 2 predict contrast-

induced nephropathy and progressive renal dysfunction: a prospective

cohort study.

Nephrol

ogy 2015;

: 552–559.

28. Moreno LO, Salvemini L, Mendonca C, Copetti M, De Bonis C, De

Cosmo S,

et al.

Serum resistin and glomerular filtration rate in patients

with type 2 diabetes.

PLoS One

2015;

: e0119529.

29. Liu G, Deng Y, Sun L, Ye X, Yao P, Hu Y,

et al

. Elevated plasma tumor

necrosis factor-a receptor 2 and resistin are associated with increased

incidence of kidney function decline in Chinese adults.

Endocrine

2016;

: 541–549.

30. Whaley-Connell A, Sowers JR. Insulin resistance in kidney disease:

Is there a distinct role separate from that of diabetes or obesity?

Cardiorenal Med

2017;

: 41–49.

31. Tomosugi SJ, Cashman H, Hay H, Pusey CD, Evans DJ, Shaw A,

et al

Modulation of antibody-mediated glomerular injury in vivo by bacterial

lipopolysaccharide, tumor necrosis factor, and IL-1.

J Immunol

1989;

142

: 3083–3090.

32. Bertani T, Abbate M, Zoja C, Corna D, Perico N, Ghezzi P,

et al

. Tumor

necrosis factor induces glomerular damage in the rabbit.

Am J Pathol

1989;

134

: 419–430.

33. Norton GR, Majane OH, Maseko MJ, Libhaber C, Redelinghuys M,

Kruger D,

et al

. Brachial blood pressure-independent relations between

radial late systolic shoulder-derived aortic pressures and target organ

changes.

Hypertension

2012;

: 885-892.

34. Woodiwiss AJ, Molebatsi N, Maseko MJ, Libhaber E, Libhaber C,

Majane OHI,

et al

. Nurse-recorded auscultatory blood pressure at a

single visit predicts target organ changes as well as ambulatory blood